IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a retrospective non-interventional study to describe the HCRU and clinical outcomes before and after AspireSR® device implantation in subjects with drug resistant epilepsy at the Queen Elizabeth Hospital, Birmingham (QEHB).
Epistemonikos ID: 7cd306ce0e17c7873931fb97f244bba702f6f00a
First added on: May 15, 2024